Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
Emenda Therapeutics works in Biotechnology Research, out of Southport, Queensland. It is privately held, and its site is emendatherapeutics.com. It holds one address on record, all in Australia. Headcount on record is 1. One Australian registration (ABN) is a confirmed match. It is listed alongside one similar brand, in Venture Capital and Private Equity Principals.
emendatherapeutics.com LinkedIn
ABN19660040442
| EMENDA THERAPEUTICS AUSTRALIA PTY LTD | ABN 19660040442 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Emenda Therapeutics is a biotech company developing small molecule kinase inhibitors to control alternative RNA splicing. We aim to treat a variety of diseases, including osteoathritis, chronic pain and cancer.
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
1 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
One Queensland entity on the ABR: EMENDA THERAPEUTICS AUSTRALIA PTY LTD (ABN 19 660 040 442), high confidence.
1 counted staff profiles at January 2026. The brand's self-reported band sits above that count and is not published as a headcount.
One address on record, Australia only. Primary: 16 Nexus Way, Southport, Queensland 4215.
None linked to this brand.
1 profile lists Emenda Therapeutics as a peer — 30th percentile in Biotechnology Research. It lists four peers of its own. D4 Bioventures lists it back.